What is it about?

The present study demonstrates that the combination therapy with telmisartan and a COX-2 inhibitor represents a novel, effective pharmacological strategy for the treatment of endometriosis.

Featured Image

Read the Original

This page is a summary of: Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions, British Journal of Pharmacology, July 2017, Wiley, DOI: 10.1111/bph.13874.
You can read the full text:

Read

Contributors

The following have contributed to this page